Thomas Zilli
@ZilliThomas
Radiation Oncology, IOSI - Oncology Institute of Southern Switzerland, EOC, Switzerland
🚨 #LowerGI highlights from #ESTRO25: 22 cutting-edge studies on #rectalcacer & #analcancer care! 💡 Discover the latest in: ✅ TNT ✅ Organ preservation ✅ QoL & PROs ✅ Dose de-escalation ✅ Prognostic biomarkers & more 👉 bit.ly/44rv3eh #Radiotherapy #radonc
Join us for the 10th Jubilee Edition of #BLADDR25! Register now: tinyurl.com/bdf4fw7y ➡️Get insights on the latest #BladderCancer data translated into clinical practice by @achoud72, @DrFelixGuerrero and many more!
🔵 🆕️ 2025 insights from the #PROFIT trial in #ProstateCancer Focusing on intermediate-risk patients treated with RT: 📌 1. Patient-reported outcomes (Sanmamed et al.) 🔹️ Hypofractionation (60 Gy/20 fx) vs. Conventional (78 Gy/39 fx) 🔹️Comparable urinary QoL 🔹️ Less…
Excited to share our newest paper on digital pathology AI biomarkers in prostate cancer RT. In this work we: ▶️performed a systematic review ▶️checked ongoing trials ▶️collected an expert consensus sciencedirect.com/science/articl… Thanks @RO_GreenJournal for accepting this work
🌻 PIC OF THE DAY by @century21fr #TDF2025 📸 A.S.O. / Ashley & Jered Gruber
Treating adrenal gland metastases with SBRT? Check out our latest guide - huge thanks to all collaborators! @ASTRO_org @ESTRO_RT @the_RSS @bslotman @SimonLo21054188 @EbnerMD @PercyLeeMD @_ShankarSiva @TugceKutukMD practicalradonc.org/article/S1879-…
❗️ Important work for SCLC 1-10 brain mets -> SRS mOS 10.2 m Only 22% of patients needed salvage WBRT Median 2 brain mets ascopubs.org/doi/10.1200/JC…
Adjuvant Chemoradiation & Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer @JAMAOnc doi.org/10.1001/jamaon… 🔎🇨🇳phs-2 trial 👉Camrelizumab > cape + RT vs obs. 👉3-year OS rate: 58.2 vs 30.5% 🧐Supports adj. Tx, ARTEMIDE-Biliary01 awaited @myESMO @EASLedu…
👀Not cancer but promising concept/result. As we expand the indication of #radiotherapy this could be an area of active interest. @SameerKeoleMD @ASTRO_org thelancet.com/journals/lance…
Can clinical complete response replace cystectomy in MIBC? The EORTC STARBURST project aims to validate MRI + biomarkers to predict response to neoadjuvant therapy—opening the door to personalized, bladder-sparing strategies. 🔗 euoncology.europeanurology.com/article/S2588-… #BladderCancer #MIBC…
(43) Due tecnici di radiologia medica | Ente Ospedaliero Cantonale (EOC) | LinkedIn linkedin.com/jobs/view/4259…
Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial sciencedirect.com/science/articl… This long-term follow-up study from the GÖTEBORG-1 screening trial evaluated outcomes in 488 men with…
💥 PEACE-V STORM final results at #ESTRO25: ENRT beats MDT for oligorecurrent nodal prostate cancer. ✔️ Better MFS (76% vs. 63%) ✔️ Improved control ✔️ Similar toxicity, fewer treatments 👉 bit.ly/46bHU6N @piet_ost @ZilliThomas
'Better technology cures more patients with less side effects' quoting @alison_tree at the MR and RT symposium in Zurich today! #radiotherapy #ProstateCancer #RadoncGU
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data sciencedirect.com/science/articl… This systematic review and meta-analysis by the DADSPORT Collaboration…
International experts/panelist of this morning at 3d summer school of adaptive radiotherapy in Negrar!! summerschoolnegrar.com #radoncs
✅ First day at the Summer School! 🌍 25 students from all continents 👨🏫 Honored to be part of a top-level faculty 🔝 🎯 Spoke about adaptive radiotherapy in bladder cancer 🚀 Great energy and interaction! #RadOnc #AdaptiveRT #BladderCancer #OncologyEducation #GlobalOncology
First day at the III Summer School of Clinical Adaptive Radiotherapy in Negrar. 3 days of lessons and hands-on sessions on #adaptiveradiotherapy Happy to learn from our incredible Faculty. #radonc #radiotherapy #mrlinac #prostatecancer @Elekta
Why attend #RENALC25, #BLADDR25 and #PROSCA25? Hear it straight from @Achard_Verane in this quick video 👇 ➡️ Register now: tinyurl.com/mryx8kwe 💎Dive into the clinical application of new GU oncology data 👥 Learn from multidisciplinary experts 🗓️3-6 December 2025 | 📍…